UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - therapeutics+%3e+immunology+and+immunotherapy
61
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Single-Chain Bispecific Chimeric Antigen Receptor Targeting BCMA and CS1 for the Treatment of Multiple Myeloma (UCLA Case No. 2018-680)
UCLA researchers in the Department of Chemical and Biomolecular Engineering have developed a single-chain bispecific chimeric antigen receptor targeting BCMA and CS1 for treating multiple myeloma. BACKGROUND: Multiple myeloma (MM) is a cancer of the plasma cells that accounts for over 30,000 new diagnoses each year, according to the American Cancer...
Published: 2/19/2025
|
Inventor(s):
Yvonne Chen
,
Eugenia Zah
Keywords(s):
Hematology
,
Immunotherapy
,
Life Science Research Tools
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Hematology
Gene Therapy for DOCK8 Deficiency (UCLA Case No. 2023-178)
UCLA researchers in the Department of Pediatrics Allergy and Immunology have developed a gene therapy method to express the full-length DOCK8 protein in cells, aimed at treating DOCK8 deficiency. These method allows for safe and effective DOCK8 expression in hematopoietic stem cells without the need for an HLA-matched donor, enabling patients to undergo...
Published: 2/18/2025
|
Inventor(s):
Caroline Kuo
Keywords(s):
bone marrow
,
bone marrow transplants
,
DOCK8
,
DOCK8 deficiency
,
Gene Editing Systems
,
Gene Therapy
,
hematopoietic stem cells
,
Immune System
,
immunodeficiency
,
Immunology
,
intein splicing
Category(s):
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Stem Cells And Regenerative Medicine
,
Life Science Research Tools > Plasmids/Vectors
A Novel Lymphocyte Stimulation Assay To Quantify Immune Responses (UCLA Case No. 2022-079)
UCLA researchers in the Department of Medicine have developed lymphocyte stimulation assays to evaluate immune responses, supporting various clinical applications such as adjusting immunosuppressant drug levels and advancing COVID-19 vaccine development. The assay systems are reliable, cost-effective, and easy-to-perform, providing accurate assessments...
Published: 2/14/2025
|
Inventor(s):
Yusaku Shino
Keywords(s):
Antibody
,
biomarkers
,
cytokines
,
Immunity (Medical)
,
immunosuppression
,
Organ Transplant
Category(s):
Life Science Research Tools > Antibodies
,
Therapeutics > Immunology And Immunotherapy
An Alternative T Cell Redirecting Bispecific Antibody Against Human Cytomegalovirus (UCLA Case No. 2024-198)
UCLA researchers in the Department of Microbiology Immunology and Molecular Genetics have created a novel T cell redirecting bispecific antibody (TRBA) for treatment of cytomegalovirus (CMV) infection. BACKGROUND: The human cytomegalovirus (CMV) has a seroprevalence of about 60% in the USA and nearly 100% of the population in some parts of the world....
Published: 2/14/2025
|
Inventor(s):
Otto Yang
Keywords(s):
Anti-CD3 antibodies
,
Bispecific antibodies
,
CD8 T cells
,
Human cytomegalovirus (CMV)
,
immunocompromised patients
,
Immunotherapy
,
Lymphocytes
,
T cell redirecting bispecific antibody (TRBA)
,
Transplant
,
Viral infection
Category(s):
Therapeutics > Infectious Diseases
,
Therapeutics > Immunology And Immunotherapy
Methods To Predict the Efficacy of Neoadjuvant Anti-PD-1 Therapy in Resectable Oral-Cavity Squamous Cell Carcinoma and Target Post-Surgical Relapses (UCLA Case No. 2022-039)
UCLA researchers in the School of Medicine have developed a novel therapeutic strategy to improve prognosis of resectable head and neck cancer patients based on clinical studies. BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is an aggressive and recurrent cancer, ranked sixth among common epithelial malignancies worldwide. Over a third...
Published: 2/14/2025
|
Inventor(s):
Roger Lo
Keywords(s):
anti-PD-1
,
head and neck cancer
,
head and neck squamous cell carcinoma (HNSCC)
,
Immunotherapy
,
oral cavity squamous cell carcinoma (OCSCC)
,
resectable tumors
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
Combination Cancer Therapy Methods and Agents (UCLA Case No. 2024-084)
UCLA researchers from the Department of Medicine, Pathology, & Laboratory Medicine and Molecular & Medical Pharmacology have identified a novel cell-based therapy that leads to enhanced immunotherapy efficacy and overcomes treatment resistance to immune checkpoint blockade in non-small cell lung cancer. BACKGROUND: Non-small cell lung cancer...
Published: 2/14/2025
|
Inventor(s):
Bin Liu
,
Steven Dubinett
Keywords(s):
anti-tumor immunity
,
cell-based therapy
,
Immune checkpoint blockade
,
Immunotherapy
,
non-small cell lung cancer
,
treatment resistance
,
Tumor microenvironment
,
Vaccines
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Respiratory And Pulmonary
Oleate-Mediated Enhancement of Human Natural Killer Cell Function (UCLA Case No. 2024-180)
UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have discovered a novel approach to boost natural killer cell function through fatty acid supplementation. BACKGROUND: Natural killer (NK) cells are part of the body’s defense system that hunts down and kills cells that are infected by viruses or have become...
Published: 2/14/2025
|
Inventor(s):
Timothy O'Sullivan
Keywords(s):
fatty acids
,
immune defense
,
immune disorders
,
Immunology
,
natural killer cells
,
nk cells
Category(s):
Therapeutics > Immunology And Immunotherapy
Functional Enrichment and Purification of a Therapeutically Superior Population of Cells (Case No. 2024-024)
Summary: UCLA researchers in the Departments of Bioengineering and Biological Chemistry have developed a method for identifying and enriching therapeutically useful cell sub-populations based on their secretions (SEC-seq). Background: Cell function is defined by a myriad of biomolecules that they secrete; over 3 thousand proteins are estimated to...
Published: 3/3/2025
|
Inventor(s):
Dino Di Carlo
,
Kathrin Plath
,
Shreya Udani
,
Justin Langerman
Keywords(s):
Cell Surface Receptor
,
Cytometry
,
Flow Cytometry
,
Functional Genomics
,
High-Throughput Screening
,
hydrogel
,
Microfluidics
,
single cell analysis
,
Therapeutics
Category(s):
Therapeutics > Immunology And Immunotherapy
,
Therapeutics
,
Therapeutics > Oncology > Oncology Immunotherapy
,
Life Science Research Tools
,
Life Science Research Tools > Research Methods
,
Diagnostic Markers > Targets And Assays
,
Therapeutics > Cell Therapy
Affinity and Functional Based Screening of T Cell Receptor Repertoire Using Nanovials (Case No. 2024-042)
Summary: Researchers in the Department of Bioengineering at UCLA have developed a hydrogel platform that measures single T cell secretions, aiding in the definition of T cell receptor repertoires for functional immunotherapy applications. Background: T cell immunotherapies, namely T cell receptor (TCR) therapies, have emerged as promising candidates...
Published: 2/14/2025
|
Inventor(s):
Dino Di Carlo
,
Owen Witte
,
Doyeon Koo
,
Zhiyuan Mao
Keywords(s):
Cancer Immunotherapy
,
CAR-T cell therapy
,
Flow Cytometry
,
hydrogel
,
Immunooncology
,
Immunotherapy
,
Peptide
,
single cell analysis
,
T Cell
,
T cell based therapy
Category(s):
Diagnostic Markers > Immunology
,
Life Science Research Tools > Screening Libraries
,
Therapeutics > Immunology And Immunotherapy
Identifying Desirable T Lymphocytes by Change in Mass Responses (Case No. 2013-183)
Summary: UCLA researchers from the Department of Pathology and Lab Medicine have developed a novel method for the identification of T lymphocytes using live cell interferometry Background: The identification of T cell receptors (TCRs) that are specific to antigens is crucial for advancing various immunotherapies. Existing methods of characterizing...
Published: 2/14/2025
|
Inventor(s):
Michael Teitell
,
Owen Witte
,
Thomas Zangle
,
Daina Burnes Linton
Keywords(s):
Category(s):
Therapeutics
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Autoimmune
,
Life Science Research Tools
,
Life Science Research Tools > Research Methods
,
Life Science Research Tools > Lab Equipment
1
2
3
4
5
6
7